The Impacts of Migraine Among Outpatients with Major Depressive Disorder at a Two-Year Follow-Up

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2015 May 23

PMID 26000962

Citations 14

Authors

Ching-I Hung

Chia-Yih Liu

Ching-Hui Yang

Shuu-Jiun Wang

Affiliations

Soon will be listed here.

Abstract

Background: No study has investigated the impacts of migraine on depression, anxiety, and somatic symptoms and remission at the two-year follow-up point among patients with major depressive disorder (MDD). This study aimed to investigate the above issues.

Methods: Psychiatric outpatients with MDD recruited at baseline were investigated at a two-year follow-up (N = 106). The Hamilton Depression Rating Scale, Hospital Anxiety and Depression Scale, and Depression and Somatic Symptoms Scale were used. Migraine was diagnosed according to the International Classification of Headache Disorders, 2nd edition. The patients were divided into no migraine, inactive migraine, and active migraine subgroups. Multiple logistic regressions were used to investigate the significant factors related to full remission of depression.

Results: Among patients without pharmacotherapy at the follow-up, patients with active migraine had significantly greater severities of anxiety and somatic symptoms as compared with patients without migraine; moreover, patients with active migraine had the lowest improvement percentage and full remission rate. There were no significant differences in depression, anxiety, and somatic symptoms between patients with inactive migraine and those without migraine. Active headache at follow-up was a significant factor related to a lower full remission rate.

Conclusions: Active headache at follow-up was associated with a lower rate of full remission and more residual anxiety and somatic symptoms at follow-up among patients with migraine. Physicians should integrate a treatment plan for depression and migraine for the treatment of patients with MDD.

Citing Articles

Risk of major mental disorders in the offspring of parents with migraine.

Li D, Tsai S, Chen T, Liang C, Chen M Ann Gen Psychiatry. 2024; 23(1):23.

PMID: 38909222 PMC: 11193281. DOI: 10.1186/s12991-024-00508-y.

Omega-3 Polyunsaturated Fatty Acids Supplementation Alleviate Anxiety Rather Than Depressive Symptoms Among First-Diagnosed, Drug-Naïve Major Depressive Disorder Patients: A Randomized Clinical Trial.

Yang R, Wang L, Jin K, Cao S, Wu C, Guo J Front Nutr. 2022; 9:876152.

PMID: 35903448 PMC: 9315396. DOI: 10.3389/fnut.2022.876152.

Migraine With Comorbid Depression: Pathogenesis, Clinical Implications, and Treatment.

Asif N, Patel A, Vedantam D, Poman D, Motwani L Cureus. 2022; 14(6):e25998.

PMID: 35865445 PMC: 9290761. DOI: 10.7759/cureus.25998.

Comparing the associations of three psychometric scales at baseline with long-term prognosis of depression over a 10-year period.

Hung C, Liu C, Hsu S, Yang C Int J Methods Psychiatr Res. 2021; 31(1):e1896.

PMID: 34714578 PMC: 8886283. DOI: 10.1002/mpr.1896.

Migraine associated with early onset postpartum depression in women with major depressive disorder.

Gordon-Smith K, Ridley P, Perry A, Craddock N, Jones I, Jones L Arch Womens Ment Health. 2021; 24(6):949-955.

PMID: 33881600 PMC: 8585813. DOI: 10.1007/s00737-021-01131-6.

References

Gudmundsson L, Scher A, Sigurdsson S, Geerlings M, Vidal J, Eiriksdottir G . Migraine, depression, and brain volume: the AGES-Reykjavik Study. Neurology. 2013; 80(23):2138-44. PMC: 3716352. DOI: 10.1212/WNL.0b013e318295d69e. View

Yavuz B, Ilgaz Aydinlar E, Yalinay Dikmen P, Incesu C . Association between somatic amplification, anxiety, depression, stress and migraine. J Headache Pain. 2013; 14:53. PMC: 3695888. DOI: 10.1186/1129-2377-14-53. View

Hung C, Liu C, Wang S, Yang C . Residual symptoms related to physical and panic symptoms at baseline predict remission of depression at follow-up. Psychopathology. 2013; 47(1):51-6. DOI: 10.1159/000348583. View

Hung C, Liu C, Chen C, Yang C, Wang S . The impacts of migraine and anxiety disorders on painful physical symptoms among patients with major depressive disorder. J Headache Pain. 2014; 15:73. PMC: 4236854. DOI: 10.1186/1129-2377-15-73. View

. The International Classification of Headache Disorders: 2nd edition. Cephalalgia. 2004; 24 Suppl 1:9-160. DOI: 10.1111/j.1468-2982.2003.00824.x. View

Hamilton M . Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol. 1967; 6(4):278-96. DOI: 10.1111/j.2044-8260.1967.tb00530.x. View

Zigmond A, SNAITH R . The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983; 67(6):361-70. DOI: 10.1111/j.1600-0447.1983.tb09716.x. View

Oedegaard K, Fasmer O . Is migraine in unipolar depressed patients a bipolar spectrum trait?. J Affect Disord. 2005; 84(2-3):233-42. DOI: 10.1016/j.jad.2003.11.007. View

Karp J, Scott J, Houck P, Reynolds 3rd C, Kupfer D, Frank E . Pain predicts longer time to remission during treatment of recurrent depression. J Clin Psychiatry. 2005; 66(5):591-7. DOI: 10.4088/jcp.v66n0508. View

10.

McIntyre R, Konarski J, Wilkins K, Bouffard B, Soczynska J, Kennedy S . The prevalence and impact of migraine headache in bipolar disorder: results from the Canadian Community Health Survey. Headache. 2006; 46(6):973-82. DOI: 10.1111/j.1526-4610.2006.00469.x. View

11.

Hung C, Weng L, Su Y, Liu C . Depression and somatic symptoms scale: a new scale with both depression and somatic symptoms emphasized. Psychiatry Clin Neurosci. 2006; 60(6):700-8. DOI: 10.1111/j.1440-1819.2006.01585.x. View

12.

Hung C, Wang S, Yang C, Liu C . The impacts of migraine, anxiety disorders, and chronic depression on quality of life in psychiatric outpatients with major depressive disorder. J Psychosom Res. 2008; 65(2):135-42. DOI: 10.1016/j.jpsychores.2008.04.011. View

13.

Smitherman T, Penzien D, Maizels M . Anxiety disorders and migraine intractability and progression. Curr Pain Headache Rep. 2008; 12(3):224-9. DOI: 10.1007/s11916-008-0039-9. View

14.

Ratcliffe G, Enns M, Jacobi F, Belik S, Sareen J . The relationship between migraine and mental disorders in a population-based sample. Gen Hosp Psychiatry. 2009; 31(1):14-9. DOI: 10.1016/j.genhosppsych.2008.09.006. View

15.

Paykel E . Partial remission, residual symptoms, and relapse in depression. Dialogues Clin Neurosci. 2009; 10(4):431-7. PMC: 3181895. View

16.

Samaan Z, Farmer A, Craddock N, Jones L, Korszun A, Owen M . Migraine in recurrent depression: case-control study. Br J Psychiatry. 2009; 194(4):350-4. DOI: 10.1192/bjp.bp.108.054049. View

17.

Pompili M, Di Cosimo D, Innamorati M, Lester D, Tatarelli R, Martelletti P . Psychiatric comorbidity in patients with chronic daily headache and migraine: a selective overview including personality traits and suicide risk. J Headache Pain. 2009; 10(4):283-90. PMC: 3451744. DOI: 10.1007/s10194-009-0134-2. View

18.

Hung C, Liu C, Cheng Y, Wang S . Migraine: a missing link between somatic symptoms and major depressive disorder. J Affect Disord. 2009; 117(1-2):108-15. DOI: 10.1016/j.jad.2008.12.015. View

19.

Tietjen G, Brandes J, Peterlin B, Eloff A, Dafer R, Stein M . Allodynia in migraine: association with comorbid pain conditions. Headache. 2009; 49(9):1333-44. DOI: 10.1111/j.1526-4610.2009.01521.x. View

20.

Heckman B, Holroyd K, Himawan L, ODonnell F, Tietjen G, Utley C . Do psychiatric comorbidities influence headache treatment outcomes? Results of a naturalistic longitudinal treatment study. Pain. 2009; 146(1-2):56-64. PMC: 2791689. DOI: 10.1016/j.pain.2009.06.019. View